Fang Zhu, Department of Entomology and Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA
Rifampin may lower repaglinide exposure, which can make blood sugar harder to control
HUBERMAN: It is clear that BPC-157 can exit the gut, but how it gets traffic to particular sites within the body that are injured still isn't clear
In a landmark 12-week-long health experiment, AOD-9604 produced intriguing results: participants who received AOD-9604 (1mg/day) experienced a greater weight loss compared to the placebo group, shedding an average of 2.6 kg compared to the placebo group's 0.8 kg
10% increase in 2024 of prescription GLP-1 and obesity drugs in the U.S
Here, we reviewed the recent progress involved in the application of biosensors that are responsive to PNPs and their precursors